PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Findr aims to automate the creation of business partnerships by providing easy access to hyper-targeted opportunities in minutes. The company asserts that its platform allows any business, regardless of its size, to sign up, post its partnership requirements, and explore opportunities for free. The company's portal allows users to request a 1-hour 'Discovery' call with a potential partner when the said user spots a relevant opportunity. Findr argues that it has made 'Discovery' for free for the first few months to build its user base. The company has onboarded 140 business users ranging from early-stage to global brands such as Mastercard, Uber and Visa since November 2020. Findr has featured in Forbes for helping businesses navigate COVID-19. The company will use the investment to develop two new price plans – Unlimited and Enterprise, introduce new platform features, hire a machine learning expert, and undertake digital activity to grow its user base.
days to go:
Expired
investment:
£396,288
Kestrl is a mobile app based on the principles of Islamic banking. It aims to cater to the over 1.9 million British Muslim community to invest in the UK in line with their religious beliefs. Consumers can avail a host of financial services from finding interest-free savings accounts to taking out a mortgage. The company raised a £135,000 pre-seed round from C-level Islamic banking professionals in January 2020. It also launched its application on Google Playstore and App store in September 2020. Kestrl is working on launching an equity-based home purchase product soon. It also aspires to expand to Malaysia/Indonesia by white labelling with established retail banks and utilising its 'inside knowledge' of the region. It will use 39% of the investment towards platform up-gradation and tech team expansion, 20% towards hiring personnel across various departments, 19% for maintaining agency license fees and acquiring its own regulatory permissions, 8% in marketing, and 14% towards ancillary costs.
days to go:
Expired
investment:
£194,502
Growth Capital Ventures (GCV) is a Financial Conduct Authority (FCA) approved fintech company. GCV's mission is to back the game changers, innovators and value creators. It is operating at three different levels namely, G-Ventures, a specialist software development division; Quva, a private investor network; and G- Labs, an innovation lab. The company aims to provide investors with access to well researched alternative investment opportunities that are selected for their potential to deliver better returns than traditional mainstream investment products. GCV has structured property transactions worth £14.7 million, has 5000+ everyday investors, and seen 500+ jobs created by portfolio companies. GCV will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£1,295,410
Born out of love and passion for fishing, Hoox Club is inspired by the competitive spirit that anglers share. The company embraces all aspects of fishing and aims to mount a global community that provides technical apparel, experiences, products and innovative fishing events. Hoox operates in a huge market that is worth over £3bn in the UK and $46bn in the US. Addressing the customer need for a high-quality fishing brand with amazing customer service, Hoox is on track in developing a collection of performance fishing clothing and accessories. The company's mission is to project the Hoox club into a 3,000 secure membership. The fund raised will be used for branding, marketing, product diversification and expanding the business across Europe.
days to go:
Expired
investment:
£21,020
Maker Life is aiming to give children the possibility to learn code, by making coding more enjoyable at a low cost. They have developed entry level build your own project kits that enable to children to take their first steps into coding.
days to go:
Expired
investment:
£68,420
